Esatoglu SN - Search Results

1

De novo manifestations during adalimumab treatment in Behçet's syndrome.

Esatoglu SN, Sonmez O, Ucar D, Kaymaz E, Ozguler Y, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Hamuryudan V, Uygunoglu U, Kutlubay Z, Hatemi AI, Celik AF, Hatemi G. Esatoglu SN, et al. Rheumatology (Oxford). 2024 Aug 7:keae416. doi: 10.1093/rheumatology/keae416. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39110537

2

Development of Posterior Uveitis in Behçet Syndrome Patients with Vitreous Cells at Baseline.

Ucar D, Bircan BE, Rustamli N, Batu Oto B, Hamuryudan V, Hatemi G, Esatoglu SN. Ucar D, et al. Among authors: esatoglu sn. Ocul Immunol Inflamm. 2024 Jul 30:1-7. doi: 10.1080/09273948.2024.2383315. Online ahead of print. Ocul Immunol Inflamm. 2024. PMID: 39079032

3

Tocilizumab may not be a good option for vascular involvement due to Behçet's syndrome.

Ozdede A, Esatoglu SN, Durmaz ES, Karakoc A, Ogun H, Hatemi G, Melikoglu M, Seyahi E. Ozdede A, et al. Among authors: esatoglu sn. Clin Exp Rheumatol. 2024 Oct;42(10):2057-2064. doi: 10.55563/clinexprheumatol/3myixe. Epub 2024 Jul 4. Clin Exp Rheumatol. 2024. PMID: 38976306 Free article.

4

A Proposal of a New Tool for the Assessment of Damage in Behçet Syndrome Uveitis: Cerrahpasa Ocular Damage Grading System.

Ozyazgan Y, Ucar D, Batu Oto B, Esatoglu SN, Ozguler Y, Hatemi G, Melikoglu M, Seyahi E. Ozyazgan Y, et al. Among authors: esatoglu sn. Ocul Immunol Inflamm. 2024 Dec;32(10):2332-2338. doi: 10.1080/09273948.2024.2352059. Epub 2024 May 20. Ocul Immunol Inflamm. 2024. PMID: 38768092

5

Validation of the Behçet's Syndrome Overall Damage Index (BODI) for Retrospective Studies and a Proposal for Modification.

Ozogul YY, Ozguler Y, Esatoglu SN, Ucar D, Uygunoglu U, Kutlubay Z, Hamuryudan V, Hatemi G. Ozogul YY, et al. Among authors: esatoglu sn. Rheumatology (Oxford). 2024 May 11:keae266. doi: 10.1093/rheumatology/keae266. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38733594

6

Hearing loss in Takayasu's arteritis.

Kimyon U, Gözen ED, Karaman E, Günay EE, Esatoglu SN, Atas A, Karaman E, Seyahi E. Kimyon U, et al. Among authors: esatoglu sn. Clin Exp Rheumatol. 2024 Apr;42(4):872-878. doi: 10.55563/clinexprheumatol/gtd2uv. Epub 2024 Mar 15. Clin Exp Rheumatol. 2024. PMID: 38489315 Free article.

7

Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis.

Erdogan M, Esatoglu SN, Kilickiran Avci B, Hatemi G. Erdogan M, et al. Among authors: esatoglu sn. Intern Emerg Med. 2024 Apr;19(3):731-743. doi: 10.1007/s11739-024-03539-1. Epub 2024 Feb 20. Intern Emerg Med. 2024. PMID: 38378970 Free PMC article.

8

HLA-B gene methylation and expression in Behçet's syndrome: a potential role of epigenetics in the pathogenesis.

Özkılınç Önen M, Everest E, Demirci T, Köprülü Şen P, Kızıltepe Kısakesen E, Özgüler Y, Esatoğlu SN, Seyahi E, Tahir Turanlı E. Özkılınç Önen M, et al. Among authors: esatoglu sn. Clin Exp Rheumatol. 2024 Oct;42(10):2014-2020. doi: 10.55563/clinexprheumatol/1sf43v. Epub 2024 Jan 24. Clin Exp Rheumatol. 2024. PMID: 38293994 Free article.

9

Disease and Treatment-Specific Complications of Behçet Syndrome.

Esatoglu SN, Ozguler Y, Hatemi G. Esatoglu SN, et al. Curr Rheumatol Rep. 2024 Jan;26(1):1-11. doi: 10.1007/s11926-023-01124-7. Epub 2023 Nov 23. Curr Rheumatol Rep. 2024. PMID: 37995045 Review.

10

Epidemiology of systemic vasculitis.

Ozguler Y, Esatoglu SN, Hatemi G. Ozguler Y, et al. Among authors: esatoglu sn. Curr Opin Rheumatol. 2024 Jan 1;36(1):21-26. doi: 10.1097/BOR.0000000000000983. Epub 2023 Oct 5. Curr Opin Rheumatol. 2024. PMID: 37800639 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters